Evidence map›Paper›PMID 35230148›Full record

Observational studyJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics2022

Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain.

Jose J Garcia-Medina, Javier Benitez-Del-Castillo, Iñaki Rodríguez-Agirretxe, Fernando Lopez-Lopez, Antonio Moreno-Valladares, VISIONARY Study Group (Spain)

Open access · hybridAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Jose J Garcia-MedinaDepartment of Ophthalmology, Hospital General Universitario Morales Meseguer, Murcia, Spain.
Javier Benitez-Del-CastilloDepartment of Ophthalmology, Hospital Universitario de Jerez, Jerez de la Frontera Cadiz, Spain.
Iñaki Rodríguez-AgirretxeDepartment of Ophthalmology, Hospital Universitario Donostia, San Sebastian Guipuzcoa, Spain.
Fernando Lopez-LopezInstituto Oftalmológico Gomez-Ulla, Santiago de Compostela Galicia, Spain.
Antonio Moreno-ValladaresDepartment of Ophthalmology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
VISIONARY Study Group (Spain)
Biogipuzkoa Health Research Institute · ESComplejo Hospitalario Universitario de Albacete · ESHospital General Universitario Morales Meseguer · ESHospital Jerez Puerta del Sur · ESInstituto de Investigaciones Agrobiológicas de Galicia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GlaucomaGlaucoma, Open-AngleOcular HypertensionAdultAgedAntihypertensive AgentsDrug CombinationsFemaleHumansIntraocular PressureMalePreservatives, PharmaceuticalProspective StudiesProstaglandinsProstaglandins AProstaglandins FAntihypertensive AgentsDrug CombinationsPreservatives, PharmaceuticalProstaglandinsProstaglandins AProstaglandins FProstaglandins, SynthetictafluprostTimololfixed-dose combinationocular hypertensionopen-angle glaucomapreservative-free topical medicationtafluprosttimolol

Identifiers

PMID35230148
PMCPMC9048172
OpenAlexW4214718970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.